YIELD10 BIOSCIENCE, INC.: insider trades · United States · SEC (Form 4)

About YIELD10 BIOSCIENCE, INC.

YIELD10 BIOSCIENCE, INC. (ticker: YTEN) is a United States agricultural bioscience company that was formerly listed on the Nasdaq Capital Market and was delisted in May 2024; its common stock subsequently became eligible for quotation on the OTC market under the YTEN symbol. For investors, this places the company in the small-cap, high-risk portion of the agribiotech universe, where valuation depends heavily on intellectual property, regulatory progress, and the ability to monetize technology through partnerships or licensing rather than on large-scale current revenues. ([sec.gov](https://www.sec.gov/Archives/edgar/data/1121702/000110465924061645/tm2414256d2_ex99-1.htm?utm_source=openai)) The company traces its roots back to 1992, when it was founded as Metabolix with an MIT-related licensing background. It later rebranded as Yield10 Bioscience to reflect a strategic pivot toward agricultural innovation and crop-yield enhancement. Yield10 is headquartered in Woburn, Massachusetts, United States, and also operates through its Canadian subsidiary, Yield10 Oilseeds Inc., in Saskatoon, Saskatchewan. ([sec.gov](https://www.sec.gov/Archives/edgar/data/1121702/000112170221000010/yten-20201231.htm?utm_source=openai)) Yield10’s core business centers on plant genetics and trait discovery through its proprietary “Trait Factory” platform, with Camelina sativa as the principal crop platform. The company is working to develop improved Camelina varieties and proprietary seed products aimed at low-carbon feedstock oils for renewable diesel and sustainable aviation fuel, omega-3 oils for aquafeed, nutrition and pharmaceutical applications, and, longer term, PHA biomaterials for biodegradable plastics. It also seeks to license yield-related traits to major seed companies for crops such as corn, soybean and canola. ([yield10bio.com](https://www.yield10bio.com/press/yield10-bioscience-announces-key-advancements-in-the-development-of-herbicide-tolerant-camelina-supporting-large-acreage-production-of-low-carbon-intensity-feedstock-oil-for-the-biofuel-market?utm_source=openai)) From a competitive standpoint, Yield10 occupies a narrow but potentially attractive niche. It is not a broad-acre agricultural input leader; instead, it competes on the quality of its genetic assets, field-validation data, and the commercial potential of Camelina as a platform crop. The investment case hinges on successfully moving from R&D to commercial adoption, securing regulatory clearances where needed, and converting scientific milestones into partner-funded commercialization. ([yield10bio.com](https://www.yield10bio.com/press/yield10-winter-camelina-proprietary-varieties-show-tolerance-commonly-used-herbicides?utm_source=openai)) Recent developments highlight both opportunity and financial strain. In July 2024, Yield10 announced an MOU and license agreement with Nuseed Nutritional US Inc. covering certain omega-3 intellectual property, materials and know-how related to Camelina, underscoring its partnership-led strategy. Earlier updates also emphasized herbicide-tolerant Camelina, seed scale-up, and commercial pathway work. At the same time, the Nasdaq delisting in 2024 marked an important negative event and suggests the company remains in a constrained financing environment. ([sec.gov](https://www.sec.gov/Archives/edgar/data/1121702/000112170224000055/exhibit991-ytenx20240712xx.htm?utm_source=openai))